Vanda Pharmaceuticals (VNDA) Free Cash Flow (2010 - 2026)
Vanda Pharmaceuticals recorded quarterly Free Cash Flow of -$50.4 million in Q1 2026, down 70.87% quarter-over-quarter from -$29.5 million in Q4 2025, and down 50.19% year-over-year from -$101.3 million in Q1 2025.
Vanda Pharmaceuticals' Free Cash Flow history runs 17 years deep, the most recent figure standing at -$50.4 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 50.19% year-over-year to -$50.4 million; the TTM figure through Mar 2026 stood at -$127.3 million (down 121.8% YoY), while the FY2025 annual figure was -$110.4 million, down 579.76% from the prior year.
- Free Cash Flow came in at -$50.4 million for Q1 2026 at Vanda Pharmaceuticals, down from -$29.5 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $31.8 million in Q1 2023 to a low of -$50.4 million in Q1 2026.
- A 5-year average of -$7.8 million and a median of -$4.0 million in 2023 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow soared 699.6% in 2023 and tumbled 1353.42% in 2025, its largest moves.
- Vanda Pharmaceuticals' Free Cash Flow stood at $9.2 million in 2022, then tumbled by 143.54% to -$4.0 million in 2023, then soared by 49.03% to -$2.0 million in 2024, then sank by 1353.42% to -$29.5 million in 2025, then sank by 70.87% to -$50.4 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$50.4 million, -$29.5 million, and -$31.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -50.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.44 Mn |
| Mar 31, 2026 | -50.44 Mn |
| Dec 31, 2025 | -29.52 Mn |
| Dec 31, 2025 | -29.52 Mn |
| Sep 30, 2025 | -31.79 Mn |
| Sep 30, 2025 | -31.79 Mn |
| Jun 30, 2025 | -15.55 Mn |
| Jun 30, 2025 | -15.55 Mn |
| Mar 31, 2025 | -33.58 Mn |
| Mar 31, 2025 | -33.58 Mn |
| Dec 31, 2024 | -2.03 Mn |
| Dec 31, 2024 | -2.03 Mn |
| Sep 30, 2024 | -14.74 Mn |
| Sep 30, 2024 | -14.74 Mn |
| Jun 30, 2024 | -7.04 Mn |
| Jun 30, 2024 | -7.04 Mn |
| Mar 31, 2024 | 7.56 Mn |
| Mar 31, 2024 | 7.56 Mn |
| Dec 31, 2023 | -3.99 Mn |
| Dec 31, 2023 | -3.99 Mn |
| Sep 30, 2023 | -2.07 Mn |
| Sep 30, 2023 | -2.07 Mn |
| Jun 30, 2023 | -13.28 Mn |
| Jun 30, 2023 | -13.28 Mn |
| Mar 31, 2023 | 31.75 Mn |
| Mar 31, 2023 | 31.75 Mn |
| Dec 31, 2022 | 9.15 Mn |
| Dec 31, 2022 | 9.15 Mn |
| Sep 30, 2022 | 12.69 Mn |
| Sep 30, 2022 | 12.69 Mn |
| Jun 30, 2022 | 5.49 Mn |
| Jun 30, 2022 | 5.49 Mn |
| Mar 31, 2022 | 3.97 Mn |
| Mar 31, 2022 | 3.97 Mn |
| Dec 31, 2021 | 26.47 Mn |
| Dec 31, 2021 | 26.47 Mn |
| Sep 30, 2021 | 9.41 Mn |
| Sep 30, 2021 | 9.41 Mn |
| Jun 30, 2021 | 18.72 Mn |
| Jun 30, 2021 | 18.72 Mn |
| Mar 31, 2021 | 9.06 Mn |
| Mar 31, 2021 | 9.06 Mn |
| Dec 31, 2020 | 18.34 Mn |
| Dec 31, 2020 | 18.34 Mn |
| Sep 30, 2020 | 9.13 Mn |
| Sep 30, 2020 | 9.13 Mn |
| Jun 30, 2020 | 23.80 Mn |
| Jun 30, 2020 | 23.80 Mn |
| Mar 31, 2020 | -1.28 Mn |
| Mar 31, 2020 | -1.28 Mn |
| Dec 31, 2019 | 9.72 Mn |
| Dec 31, 2019 | 9.72 Mn |
| Sep 30, 2019 | 5.70 Mn |
| Sep 30, 2019 | 5.70 Mn |
| Jun 30, 2019 | 20.25 Mn |
| Jun 30, 2019 | 20.25 Mn |
| Mar 31, 2019 | 9.25 Mn |
| Mar 31, 2019 | 9.25 Mn |
| Dec 31, 2018 | 15.24 Mn |
| Dec 31, 2018 | 15.24 Mn |
| Sep 30, 2018 | 8.56 Mn |
| Sep 30, 2018 | 8.56 Mn |
| Jun 30, 2018 | 4.32 Mn |
| Jun 30, 2018 | 4.32 Mn |
| Mar 31, 2018 | 1.50 Mn |
| Mar 31, 2018 | 1.50 Mn |
| Dec 31, 2017 | 3.28 Mn |
| Dec 31, 2017 | 3.28 Mn |
| Sep 30, 2017 | 1.80 Mn |
| Sep 30, 2017 | 1.80 Mn |
| Jun 30, 2017 | -2.88 Mn |
| Jun 30, 2017 | -2.88 Mn |
| Mar 31, 2017 | -5.84 Mn |
| Mar 31, 2017 | -5.84 Mn |
| Dec 31, 2016 | -1.88 Mn |
| Dec 31, 2016 | -1.88 Mn |
| Sep 30, 2016 | 642,000.00 |
| Sep 30, 2016 | 642,000.00 |
| Jun 30, 2016 | -3.26 Mn |
| Jun 30, 2016 | -3.26 Mn |
| Mar 31, 2016 | -4.90 Mn |
| Mar 31, 2016 | -4.90 Mn |
| Dec 31, 2015 | -1.07 Mn |
| Dec 31, 2015 | -1.07 Mn |
| Sep 30, 2015 | -5.73 Mn |
| Sep 30, 2015 | -5.73 Mn |
| Jun 30, 2015 | 11.95 Mn |
| Jun 30, 2015 | 11.95 Mn |
| Mar 31, 2015 | 4.77 Mn |
| Mar 31, 2015 | 4.77 Mn |
| Dec 31, 2014 | -13.72 Mn |
| Dec 31, 2014 | -13.72 Mn |
| Sep 30, 2014 | -7.65 Mn |
| Sep 30, 2014 | -7.65 Mn |
| Jun 30, 2014 | -36.91 Mn |
| Jun 30, 2014 | -36.91 Mn |
| Mar 31, 2014 | -24.04 Mn |
| Mar 31, 2014 | -24.04 Mn |
| Dec 31, 2013 | -12.25 Mn |
| Dec 31, 2013 | -12.25 Mn |
| Sep 30, 2013 | -10.28 Mn |
| Sep 30, 2013 | -10.28 Mn |
| Jun 30, 2013 | -8.09 Mn |
| Jun 30, 2013 | -8.09 Mn |
| Mar 31, 2013 | -9.15 Mn |
| Mar 31, 2013 | -9.15 Mn |
| Dec 31, 2012 | -13.86 Mn |
| Dec 31, 2012 | -13.86 Mn |
| Sep 30, 2012 | -10.18 Mn |
| Sep 30, 2012 | -10.18 Mn |
| Jun 30, 2012 | -12.36 Mn |
| Jun 30, 2012 | -12.36 Mn |
| Mar 31, 2012 | -10.54 Mn |
| Mar 31, 2012 | -10.54 Mn |
| Dec 31, 2011 | -12.43 Mn |
| Dec 31, 2011 | -12.43 Mn |
| Sep 30, 2011 | -7.20 Mn |
| Sep 30, 2011 | -7.20 Mn |
| Jun 30, 2011 | -5.62 Mn |
| Jun 30, 2011 | -5.62 Mn |
| Mar 31, 2011 | -3.26 Mn |
| Mar 31, 2011 | -3.26 Mn |
| Dec 31, 2010 | -5.10 Mn |
| Dec 31, 2010 | -5.10 Mn |
| Sep 30, 2010 | -5.07 Mn |
| Sep 30, 2010 | -5.07 Mn |